- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Torrent Pharmaceuticals shareholders have approved all resolutions at the 52nd Annual General Meeting. This includes adopting FY25 financial results and confirming a total dividend of ₹32.00 per share (₹26.00 interim, ₹6.00 final). Shareholders endorsed Aman Mehta's appointment as Managing Director. Importantly, the company secured approval to increase its borrowing limit from ₹15,000 Cr to ₹26,000 Cr, create charges on assets, and enhance its capacity for loans and investments. The ability to issue equity or convertible instruments was also approved, boosting financial flexibility for future growth.